protocatechualdehyde has been researched along with Disease Models, Animal in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Ahn, G; Fernando, IPS; Han, EJ; Heo, SJ; Kim, EA; Kim, J; Kim, KN; Oh, JY | 1 |
Chang, CH; Chang, YT; Chiu, KH; Chung, MC; Shieh, JJ; Wu, MJ | 1 |
Ding, Y; Duan, J; Guan, Y; Guo, C; Ma, S; Quan, W; Wang, J; Wen, A; Yin, Y; Zhang, W; Zhang, Y; Zhu, J | 1 |
Guo, Q; Jiang, Y; Tu, PF; Wan, YJ; Wang, YH; Zeng, KW | 1 |
He, Y; Li, W; Shao, C; Wan, H; Yang, J; Zeng, J; Zeng, M; Zhao, X; Zhou, H | 1 |
Chu, L; Gao, YG; Ma, JJ; Wang, JY; Wang, N; Xie, Y; Zhang, FH; Zhang, JP; Zhang, Y; Zhang, YY | 1 |
Chen, C; Lü, JM; Yao, Q | 1 |
An, MS; Ge, HQ; Liu, JH; Pu, XP; Wang, YH; Yang, YF; Zhai, S; Zhao, X | 1 |
Cho, YH; Kong, BS; Lee, EJ | 1 |
Hou, J; Jiang, WL; Xu, Y; Zhang, SP; Zhu, HB | 1 |
Hou, J; Jiang, W; Li, C; Zhu, H | 1 |
11 other study(ies) available for protocatechualdehyde and Disease Models, Animal
Article | Year |
---|---|
Anti-Allergic Effect of 3,4-Dihydroxybenzaldehyde Isolated from
Topics: Animals; Anti-Allergic Agents; Benzaldehydes; Catechols; Cells, Cultured; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Immunoglobulin E; Male; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Passive Cutaneous Anaphylaxis; Rhodophyta; Serum Albumin, Bovine | 2022 |
Anti-EMT and anti-fibrosis effects of protocatechuic aldehyde in renal proximal tubular cells and the unilateral ureteral obstruction animal model.
Topics: Animals; Benzaldehydes; Cadherins; Catechols; Collagen; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Kidney Diseases; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ureteral Obstruction; Vimentin | 2022 |
Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both
Topics: Animals; Apoptosis; Benzaldehydes; Catechols; Cell Line, Tumor; Disease Models, Animal; Dopaminergic Neurons; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; NF-E2-Related Factor 2; Parkinson Disease; Phytotherapy; Protein Serine-Threonine Kinases; Salvia miltiorrhiza; Signal Transduction | 2019 |
Protocatechualdehyde protects oxygen-glucose deprivation/reoxygenation-induced myocardial injury via inhibiting PERK/ATF6α/IRE1α pathway.
Topics: Activating Transcription Factor 6; Animals; Apoptosis; Benzaldehydes; Catechols; Cell Hypoxia; Cell Line; Disease Models, Animal; eIF-2 Kinase; Endoplasmic Reticulum Stress; Endoribonucleases; Fibrosis; Glucose; Male; Mice, Inbred C57BL; Multienzyme Complexes; Myocardial Reperfusion Injury; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcriptome | 2021 |
Protocatechudehyde improves mitochondrial energy metabolism through the HIF1α/PDK1 signaling pathway to mitigate ischemic stroke-elicited internal capsule injury.
Topics: Animals; Apoptosis; Benzaldehydes; Brain Ischemia; Catechols; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Metabolism; Hypoxia-Inducible Factor 1, alpha Subunit; Internal Capsule; Ischemic Stroke; Male; Membrane Potential, Mitochondrial; Neuroprotective Agents; PC12 Cells; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2021 |
Salvia miltiorrhiza (Danshen) injection ameliorates iron overload-induced cardiac damage in mice.
Topics: Animals; Benzaldehydes; Benzofurans; Catechols; Chromatography, High Pressure Liquid; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glutathione Peroxidase; Heart; Injections, Intraperitoneal; Iron Overload; L-Lactate Dehydrogenase; Lactates; Male; Medicine, Chinese Traditional; Mice; Myocardium; Phenanthrolines; Salvia miltiorrhiza; Superoxide Dismutase | 2013 |
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Topics: Administration, Oral; Allopurinol; Animals; Antioxidants; Benzaldehydes; Catechols; Cell-Free System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Molybdenum; Reactive Oxygen Species; Structure-Activity Relationship; Uric Acid; Xanthine Oxidase | 2013 |
Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Benzaldehydes; Catechols; Cell Line, Tumor; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Oncogene Proteins; Parkinson Disease; PC12 Cells; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Substantia Nigra | 2013 |
G protein-coupled estrogen receptor-1 is involved in the protective effect of protocatechuic aldehyde against endothelial dysfunction.
Topics: Animals; Aorta, Thoracic; Benzaldehydes; Benzodioxoles; Carotid Artery Injuries; Catechols; Cyclic AMP; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Hydrogen Peroxide; Male; Neointima; Organ Culture Techniques; Quinolines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2014 |
Protocatechuic aldehyde protects against experimental sepsis in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Benzaldehydes; Catechols; Cell Line; Disease Models, Animal; Drug Therapy, Combination; HMGB1 Protein; Imipenem; Inflammation; Inflammation Mediators; Injections, Intravenous; Interleukin-10; Macrophages; Male; NF-kappa B; Phosphorylation; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2012 |
Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis.
Topics: Animals; Benzaldehydes; Blotting, Western; Carbon Tetrachloride; Catechols; Cell Proliferation; Cells, Cultured; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hepatic Stellate Cells; Hyaluronic Acid; Immunohistochemistry; Laminin; Liver; Liver Cirrhosis; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2012 |